Thursday, November 01, 2018 8:59:47 AM
I am posting this article because much of the logic for moving from hospital administered IV to wearable devices is applicable to the RMS product line. More specifically cost savings and convenience. Also the reformulation and optimization of IV drugs for SC infusions can be accelerated via partnerships between drug makers and device manufactures such as RMS.
https://drug-dev.com/wearable-injectors-a-small-device-that-can-make-a-big-difference-for-iv-infusion/
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM